However, WB showed that there was no statistically significant difference in the increase in p‐tau expression levels in the brains of AD mice compared to that in the control group (Figure 7F), suggesting that hyperphosphorylated tau was not the first to appear in the pathological evolution of AD. Here, MAPT is linked to Alzheimer disease.